Episodes (Page 29)
✨
US Inflation Reduction Act and drug pricing trends discussed.
✨
Big deals in radiopharmaceuticals and BioNTech's ADC pipeline.
✨
Discussion on the proposed US BIOSECURE Act.
Kevin Duan
✨
Mifepristone access and misinformation at the Supreme Court.
✨
EU's AI Act and its impact on digital health.
Andrew Trister
✨
Galderma challenges Dupixent; Pfizer's Adcetris plans.
Greg Meyers
✨
Marni Allen discusses personalized wellness with Bioniq.
Marni Allen
✨
MindMed advances LSD therapy for anxiety into Phase III.
✨
Identifying undiagnosed and misdiagnosed patients is crucial.
Vibhor Gupta
✨
Bayer decides against splitting; Pfizer's next-gen ADC pipeline.
✨
Vanda sues FDA over jet lag indication denial.
✨
Global experts predict advancements in therapeutic areas for 2024.
✨
Augmented reality in medical products discussed.
✨
iRhythm CEO discusses new long-term cardiac monitor.
Quentin Blackford
✨
Optimistic outlook for biopharma IPOs.
✨
Kenvue discusses the 'beauty-from-within' supplements market.
Kenvue's Paul LaTerra
✨
NodThera develops brain-penetrant NLRP3 inflammasome inhibitors.
Alan Watt
✨
Expected trends and upcoming events in therapy areas for 2024.
✨
Bayer is strategically reducing debt.
ex-Daiichi Sankyo CEO
✨
FDA's evolving stance on psychedelic drug approvals.